Global,Erythropoietin,Drugs,Ma marketing Global Erythropoietin Drugs Market 2016: Industry Demand, Se

Automation technologies represent a fundamental aspect of any modern industry. The major types of industrial automation solutions, such as DCS, PLC, SCADA, and MES, are used on a large-scale in process and discrete industries.DCS technologie Awhile ago, I got an email from one of the "gurus" I follow and it shocked me. The gist of it was this person wanted to trade services for a household item.To say it floored me would be an understatement.What was worse was a few days later t

Erythropoietin is a glycoprotein hormone synthesized in the bone marrow that controls and regulates the mechanism of erythropoiesis (production of red blood cells). These erythropoietin drugs are used for treatment of chemotherapy-induced anemia; anemia is a common side-effect occurring due to chemotherapy of End Stage Renal Diseases (ESRD), cancer and HIV. Improved recombinant DNA technology has led to development of synthetic forms of erythropoietin such as epoetin alfa, epoetin beta, darbepoetin alfa, epoetin omega, and epoetin delta among the others. The global EPO drugs market is thus driven by increasing number of patients suffering from anemic condition induced due to cancer, HIV and ESRD treatment; favorable reimbursements and increasing commercialization of EPO biosimilars. The global EPO drugs market would reach $11.9 billion by 2020, registering CAGR of 9.7% during 2014-2020.Amongst all synthetic erythropoietin products, Epoetin alfa and its advance version, Darbepoetin alfa, are the most popular drugs. Epoetin alfa and Darbepoetin alfa collectively accounted for ~80% of total EPO drugs market revenue. Amgen Inc. was first company to innovate Epoetin alfa and Darbepoetin alfa that are branded/patented as Epogen and Aranesp respectively. However, expiration of Amgen’s patent for Epogen has aided manufacturers of biosimilars to enter the EPO drugs market. Availability of numerous biosimilars has rendered low-cost option to the patients, therefore increased adoption rates for EPO drugs particularly in the developing regions.Get Free Sample Report of Erythropoietin Drugs Market: http://www.intenseresearch.com/market-analysis/global-erythropoietin-drugs-market-products-applications-and-geography.html#request-sampleBased on the applications, the global EPO drugs market is segmented into anemia associated with End Stage Renal Diseases (ESRD), cancer chemotherapy and, antiretroviral treatment (ART). Current research is focused toward expanding the applications of EPO drugs in other disease conditions such as neural diseases and wound healing. Global EPO drugs market is segmented based on geography into North America, Europe, Asia Pacific and LAMEA. Europe is the leading geographical market owing to favorable reimbursement policies and less stringent and speedy regulatory approvals for EPO drugs.Key companies profiled in the report are, Amgen Inc., Johnson & Johnson, Hospira Inc., Roche, LG Life Sciences Ltd., Biocon, Intas Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Celltrion, Inc.Get Full Table Of Content (Index) Of Erythropoietin Drugs Market: http://www.intenseresearch.com/market-analysis/global-erythropoietin-drugs-market-products-applications-and-geography.html#table-of-content Table Of Content Of Erythropoietin Drugs Market:CHAPTER 1 INTRODUCTION 1.1 Key Benefits 1.2 Key Market Segments 1.3 Research Methodology 1.3.1 Primary Research 1.3.2 Secondary Research 1.3.3 Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARY 2.1 Market beyond what to expect by 2025 ($Million) 2.1.1 Moderate growth scenario 2.1.2 Rapid growth scenario 2.1.3 Diminishing growth scenarioCHAPTER 3 MARKET OVERVIEW 3.1 Market definition and scope 3.2 Evolution of Erythropoietin drugs 3.3 Erythropoietin Omega and Delta: pruned R&D pipeline drugs 3.4 Ethical considerations of erythropoietin drugs 3.5 Key findings 3.5.1 Top Factors Impacting for Global Erythropoietin Drugs Market 3.5.2 Top Investment Pockets for Global Erythropoietin Drugs Market 3.6 Value Chain Analysis 3.7 Key market player positioning (2014) 3.8 Product positioning for patented products (2014) 3.9 Clinical trials for EPO drug in neural diseases and wound healing 3.10 Competitive Intelligence on top three leaders (Amgen, J&J and Roche) 3.11 Market share analysis, 2013 3.12 Market dynamicsAbout Intense ResearchIntense Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Intense Research cover more than 30 industries includsing energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with one-stop solution for all the research requirements.Contact Us:Joel John 3422 SW 15 Street, Suit #8138, Deerfield Beach, Florida 33442, United States Tel: +1-386-310-3803 GMT Tel: +49-322 210 92714 USA/Canada Toll Free No. 1-855-465-4651 Email: [email protected]   Web: http://www.intenseresearch.com/